Topic: Benjamin N. Cardozo School of Law
They filed a lawsuit arguing that those for breast cancer genes BRCA1 and BRCA2, controlled by the diagnostic company Myriad Genetics in Salt Lake City, Utah, are illegal. The litigation is being carried forward by the Public Patent Foundation, headed by Daniel ...